Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) concerning possible violations of federal securities laws.

If you purchased shares of Envision and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

The investigation focuses on whether Envision and certain of its officers and/or directors violated federal securities laws. On July 24, 2017, The New York Times reported that physicians associated with the Company’s subsidiary, EmCare Holdings Inc., were disproportionately likely to engage in practices such as surprise billing in which patients who go to in-network hospitals are treated by out-of-network doctors, who then bill them at higher rates. When this news was announced, shares of Envision fell in value.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.